Intended for healthcare professionals

Letters Long live generics!

Generics have a chequered recent history

BMJ 2016; 355 doi: (Published 05 December 2016) Cite this as: BMJ 2016;355:i6527
  1. Shyan Goh, orthopaedic surgeon
  1. Sydney, NSW 2152, Australia
  1. sgoh{at}

I’m surprised that McCartney didn’t mention the US version of the phenytoin fiasco1; Martin Shkreli, the chief executive officer of Turing Pharmaceuticals was dubbed the most hated man in America in 2015 after a 5556% price hike of the antiparasitic drug Daraprim (pyrimethamine), from $13 (£10; €12) to $750 a tablet. He …

View Full Text

Log in

Log in through your institution


* For online subscription